Study results demonstrated significant correlations between fatigue and reductions in walking speed and mobility among patients with multiple sclerosis. People with MS often experience fatigue, with ...
A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability ...
—A small study of 99 patients with relapsing-remitting multiple sclerosis found that moderately and severely frail participants demonstrated slower walking speeds, lower cadence (steps per minute), ...
ORLANDO — An extended-release (ER) formulation of amantadine hydrochloride known as ADS-5102 (Adamas Pharmaceuticals) may be safe and effective for patients with walking impairment from multiple ...
MILAN — A specially adapted frame to support individuals with walking and balance disabilities could help people with multiple sclerosis engage in moderate-to-vigorous physical activity and improve ...
WASHINGTON (Reuters) - A drug being developed by Acorda Therapeutics Inc helps some people with multiple sclerosis walk better, an important step in improving their quality of life, U.S. researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results